Clinicopathological features of olfactory carcinoma.
10.3760/cma.j.cn112151-20230208-00101
- Author:
C C ZHANG
1
;
H LI
1
;
L Q CHENG
1
;
H B WU
1
Author Information
1. Center of Clinical Pathology, the First Affiliated Hospital of University of Science and Technology of China/Anhui Provincial Hospital, University of Science and Technology of China, Hefei 230036, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Male;
Female;
Middle Aged;
Paranasal Sinus Neoplasms/chemistry*;
Biomarkers, Tumor/metabolism*;
Carcinoma/chemistry*;
Diagnosis, Differential;
S100 Proteins;
DNA Helicases/metabolism*;
Nuclear Proteins/metabolism*;
Transcription Factors/metabolism*
- From:
Chinese Journal of Pathology
2023;52(11):1138-1143
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinicopathological features and differential diagnosis of olfactory carcinoma (OC). Methods: Twenty-one cases of sinonasal tumors, including those initially diagnosed as olfactory neuroblastoma (ONB) and those with uncertain diagnosis, were collected from the Department of Pathology, the First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) from January 2016 to August 2022, among which 3 cases were reclassified as OC. The clinicopathological features were investigated, and the remaining 18 cases were used as control. Results: Of the three OC patients, 2 were male and 1 was female, with an average age of 57 years ranging from 35 to 74 years. Microscopically, the tumor cells were arranged in solid, nested or lobulated patterns with occasional palisading around the solid nests. The stroma was highly vascular with focal neurofibrillary areas. There were prominent rosettes or pseudorosettes formation. The tumor cells were mainly ovoid to spindly with scant to moderate amount of cytoplasm, one or several small nucleoli, and fine chromatin content. Brisk mitotic figures were seen. In all 3 cases of OC, there were scanty atypical glands and some were ciliated. Immunohistochemically, at least one epithelial marker and neuroendocrine marker were diffusely expressed in the tumor. Some of the tumor cells were positive for p40 and p63, and the sustentacular cells showed the expression of S-100 protein. All cases tested were negative for NUT, CD99 and desmin, with intact expression of SMARCA4 (BRG1) and SMARCB1 (INI-1). Ki-67 proliferation index varied from 20% to 80%. Follow-up after 16-18 months showed no mortality with tumor recurrence from 1 patient after 16 months. Conclusion: OC is a rare sinonasal tumor with neuroepithelial differentiation, its histomorphology is diverse, and the combination of immunohistochemical markers is essential for appropriate diagnosis.
